To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
Not yet recruiting · NCT07406438 · Registry updated 2026-02-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD) | Neovascular Age-Related Macular Degeneration (nAMD) | Not yet recruiting | Phase 1 | 2026-02-12 | NCT07406438 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shenzhen Kexing Pharmaceutical Co., Ltd. | 3 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Tongren Hospital, Capital Medical University | Beijing | China | 11 |
| Henan Provincial Eye Hospital | Zhengzhou | China | 1 |
| Nanchang University Second Affiliated Hospital | Nanchang | China | 1 |
| Sir Run Run Shaw Hospital (SRRSH), affiliated with Zhejiang University School of Medicine | Hangzhou | China | 1 |
| The Affiliated Hospital of Guizhou Medical University | Guiyang | China | 20 |
| Zhejiang Provincial People's Hospital | Hangzhou | China | 48 |